Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
GLAXOSMITHKLINE Plc chief executive officer Andrew Witty is willing to consider suggestions made by investors to break up the company - although it may not happen for at least a year or two.
A deal with Novartis AG that closed in March created market-leading businesses in...